How many insider declarations has Inscobee Inc. filed?

Inscobee Inc. has filed 2 public insider declarations with SEC (Form 4).

What is Inscobee Inc.'s role?

Inscobee Inc.'s reported role is not specified by the regulator across the filings.

Which companies does Inscobee Inc. report trades for?

Inscobee Inc. reports trades for Apimeds Pharmaceuticals US, Inc..

What is Inscobee Inc.'s declared buy vs sell volume?

Across the available history, declared buys total 1.8M€ and disposals 0.

← Executives ★ Sign in to follow

II

Inscobee Inc.

·SEC (Form 4)

Apimeds Pharmaceuticals US, Inc.

0

Total declarations

0

Company

€2m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-6.4%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the detailed record of transactions filed by Inscobee Inc.. Officer active across 1 company, notably Apimeds Pharmaceuticals US, Inc.. Cumulatively, 2 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €1.8m. Activity tracked since 12 May 2025. The latest transaction was filed on 12 May 2025 (C). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Inscobee Inc.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Apimeds Pharmaceuticals US, Inc. (US)

Declarations2 total

●

Inscobee Inc.

Executives12 May 2025Apimeds Pharmaceuticals US, Inc.

$184,8347SEC ↗

71,090 shares@ US$2.608.5% of flowCommon Stock, par value $0.01 per shareSEC:0001474506-25-000109:0

▲

Inscobee Inc.

Executives12 May 2025Apimeds Pharmaceuticals US, Inc.

$2M29SEC ↗

500,000 shares@ US$4.00100.0% of flowCommon Stock, par value $0.01 per shareSEC:0001474506-25-000089:0

Canonical exit: 10 Aug 2025 (T+90)

2 of 2 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

II

Inscobee Inc.

·SEC (Form 4)

Apimeds Pharmaceuticals US, Inc.

0

Total declarations

0

Company

€2m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-6.4%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the detailed record of transactions filed by Inscobee Inc.. Officer active across 1 company, notably Apimeds Pharmaceuticals US, Inc.. Cumulatively, 2 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €1.8m. Activity tracked since 12 May 2025. The latest transaction was filed on 12 May 2025 (C). Regulator: SEC (Form 4). The full history is openly available.